Tokyo - Delayed Quote JPY

Welcia Holdings Co., Ltd. (3141.T)

2,475.00
+20.00
+(0.81%)
At close: 3:30:00 PM GMT+9
Loading Chart for 3141.T
  • Previous Close 2,455.00
  • Open 2,421.50
  • Bid 2,475.00 x --
  • Ask 2,479.00 x --
  • Day's Range 2,420.00 - 2,480.00
  • 52 Week Range 1,816.00 - 2,613.00
  • Volume 731,400
  • Avg. Volume 923,074
  • Market Cap (intraday) 513.768B
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) 34.29
  • EPS (TTM) 72.18
  • Earnings Date Jul 7, 2025 - Jul 11, 2025
  • Forward Dividend & Yield 36.00 (1.47%)
  • Ex-Dividend Date Aug 28, 2025
  • 1y Target Est 2,203.33

Welcia Holdings Co., Ltd., together with its subsidiaries, operates a chain of drug stores with dispensing pharmacies in Japan. Its stores offer OTC products, cosmetics, household goods, food, and other products. The company also offers counseling, late-night, and long-term care services, as well as home-visit bathing and nursing care support services, as well as housing services for elderly people. It also engages in the retail of daily necessities, foods, confectionary, alcohol, etc. The company was formerly known as Growell Holdings Co., Ltd. and changed its name to Welcia Holdings Co., Ltd. in September 2012. Welcia Holdings Co., Ltd. was founded in 1935 and is headquartered in Tokyo, Japan. Welcia Holdings Co., Ltd. is a subsidiary of Aeon Co., Ltd.

www.welcia.co.jp

--

Full Time Employees

February 28

Fiscal Year Ends

Recent News: 3141.T

View More

Performance Overview: 3141.T

Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

3141.T
21.49%
Nikkei 225 (^N225)
7.29%

1-Year Return

3141.T
12.10%
Nikkei 225 (^N225)
4.22%

3-Year Return

3141.T
1.43%
Nikkei 225 (^N225)
38.32%

5-Year Return

3141.T
38.10%
Nikkei 225 (^N225)
81.41%

Compare To: 3141.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 3141.T

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    509.62B

  • Enterprise Value

    555.85B

  • Trailing P/E

    34.01

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.40

  • Price/Book (mrq)

    2.05

  • Enterprise Value/Revenue

    0.43

  • Enterprise Value/EBITDA

    10.43

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.16%

  • Return on Assets (ttm)

    3.99%

  • Return on Equity (ttm)

    5.75%

  • Revenue (ttm)

    1.29T

  • Net Income Avi to Common (ttm)

    14.96B

  • Diluted EPS (ttm)

    72.18

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    35.01B

  • Total Debt/Equity (mrq)

    31.93%

  • Levered Free Cash Flow (ttm)

    31.02B

Research Analysis: 3141.T

View More

Company Insights: 3141.T

Research Reports: 3141.T

View More

People Also Watch